Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.16
Delayed Data
As of Jun 30
 -0.02 / -1.69%
Today’s Change
0.64
Today|||52-Week Range
5.80
-20.00%
Year-to-Date
Health Insurers: a Surprising Key to Drugmakers' Sucess
Jun 30 / MotleyFool.com - Paid Partner Content
MannKind Corp. Shares Are Down 28.3% So Far This Year. Here's Why.
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close1.18
Today’s open1.13
Day’s range1.12 - 1.16
Volume1,935,738
Average volume (3 months)6,157,453
Market cap$563.7M
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.18%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.20-1.92%
EGRXEagle Pharmaceutical...-0.13-0.33%
CORTCorcept Therapeutics...0.000.00%
DVAXDynavax Technologies...0.000.00%
Data as of 06/30/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Partner Offers

Search for Jobs